Navigation Links
HRT Found To Increase Recurrence of Breast Cancer

A new study assessing the use of hormone replacement therapy among breast cancer survivors has been // stopped early because results indicate an unacceptably high rate of recurring or new cancers.

Swedish researchers embarked on the study in part because more women are surviving the disease and therefore subject to the same menopausal symptoms as other women. The study was expected to involve around 1,300 women over five years. After the initial 345 women in the study were followed for about two years, however, results showed 26 of those randomized to receive HRT experienced a new or recurring cancer, compared to just seven in a placebo group. The risk was deemed unacceptable, and the study was halted on December 17, 2003.

Noting some doctors prescribe HRT for their breast cancer patients with severe menopausal symptoms because observational studies have suggested no harm from the treatment, specialists say , “This study will no doubt change that. It is large enough and clear enough to show that HRT appears to increase the chance of a new or recurring breast cancer. Because of that, offering HRT to women with a history of breast cancer would be unwise.”

Researchers conclude saying , alternative safe and effective strategies for the difficult problem of menopausal symptoms in these women now need to be developed.
'"/>




Page: 1

Related medicine news :

1. Fluoride Found Effective in Osteoporosis
2. Implantable Contact Lens Found Safe and Effective
3. Cancer hazard Found With Animal-Based Nutrients
4. Processed Meat, Diabetes connection Found
5. Night Time Aspirin Regimen Found to Reduce Blood Pressure
6. Hydrotherapy Found to be Effective for Patients with Osteoarthritis
7. Hydrotherapy Found to be Effective for Patients with Osteoarthritis
8. Preventive Therapies Found to be More Effective in Managing Migraines
9. Common Cold Found to Fight Cancer
10. Circumcision Found To Prevent HIV Spread
11. Drug Found To Reduce The Transmission Of Herpes
Post Your Comments:
(Date:10/10/2008)...CITY, Utah, Oct. 10 /PRNewswire/ -- NuView Life Sc...nt of Trace Life Sciences Inc.,(Trace), including ...,production facilities in Denton, Texas. The Trace...11, Iodine-123 and Thallium-201 used in,molecular ...hairman and,CEO, stated that "We are confident tha...
(Date:10/10/2008)...gests poor self-care partly to blame , ,... Medicare beneficiaries who have diabetes, being d...according to a new study. , Publishing in the... Medicine , researchers from the University of Was...rage age of 75.6 years) who had diabetes and were ...
(Date:10/10/2008)...l Institutes of Health (NIH) scientists have ident...key types of white blood cells, T and B cells, ena... establishing long-lasting immunity after an infec...ividuals who have a genetic defect that prevents t...lethal infections with a common virus that otherwi...
(Date:10/10/2008)...DELPHIA, Oct. 10 /PRNewswire/ -- The Mobile Massag...ding provider of on-site seated massage,services f..., and special,affairs, announced today that it is ...sylvania and the greater Philadelphia metropolitan...ing interest in our on-site,seated, massage progr...
Breaking Medicine News(10 mins):Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:NIH scientists discover crucial control in long-lasting immunity 2Health News:NIH scientists discover crucial control in long-lasting immunity 3Health News:Mobile Massage Team Announces Expansion of On-Site Seated Massage Services Throughout Eastern Pennsylvania and the Greater Philadelphia Region 2
...ract symptoms who received a combination therapy w...than men who// received only one medication, accor...a theme issue on men's health. Steven A. Kaplan,...e, New York, presented the findings of the study t...
...Minister has said that to shut out traditional med...the name of safety would be// against the interest...ing at a two day International Conclave on Traditi...e said that in the global society we live in today...
...have been sequencing the genome of an organism cal...encing effort of a complete// genome that holds pr...ing tuberculosis and leprosy. Recent evidence tha...cally reduces treatment time of tuberculosis (TB) ...
...Duchenne Muscular Dystrophy, an extremely debilita...mitted their findings// recently. The Stem cell S...m to offer hope for those who suffer from the dise...hy is a severe progressive disease of genetic ori...
Other Medicine News:Health News:Combination Therapy More Effective for Treating Lower Urinary Tract Symptoms 2Health News:Two Day International Conclave on Traditional Medicine Inaugurated 2Health News:Two Day International Conclave on Traditional Medicine Inaugurated 3Health News:India Finds New Use for an Old Bug 2Health News:India Finds New Use for an Old Bug 3
(Date:10/8/2008)...eers Research That May Offer New Hope to,Heart Fai...tionally, over 3,000 people are,waiting for a hear...y half,of those will receive a transplant. Now, pi... is paving the way for how to treat congestive hea...a News Release, go to:, http://www.prnewswire.com/...
(Date:10/8/2008)...wire/ -- Vical Incorporated (Nasdaq: VICL ),today...linical data,demonstrating that the company,s Vaxf...- and protein-based infectious disease vaccines an... Pharm.D., Ph.D., Vical,s,Senior Vice President of...,Wednesday, October 8, at the World Vaccine Congre...
(Date:10/7/2008)...swire/ -- The Texas Cardiac Arrhythmia,Institute (...ted as one of,only a few sites in the nation to pa...new device to treat persistent atrial fibrillation...esearch center specializing in heart,rhythm disord...Center and,Texas Cardiovascular Consultants., "Th...
(Date:10/7/2008)...s, VYVANSE taken once-daily significantly,improved...IA, Oct. 7 /- Shire plc (LS...armaceutical company, today,announced that a study...f,Clinical Psychiatry found once-daily VYVANSE sig...y Disorder (ADHD) symptoms in adults within,the fi...
Breaking Medicine Technology:Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 2Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 3Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 2Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 3Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 4Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 5Texas Cardiac Arrhythmia Institute at St. David's Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation 2Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 2Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 3Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 4Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 5Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 6AutismCares Offers Support to Families Affected by California Fires 4674 1AutismCares Offers Support to Families Affected by California Fires 4674 2AutismCares Offers Support to Families Affected by California Fires 4674 3Paratek Pharmaceuticals Announces the Close of 2440 Million Private Placement to Finance Programs to Combat MRSA Infections 671 1Paratek Pharmaceuticals Announces the Close of 2440 Million Private Placement to Finance Programs to Combat MRSA Infections 671 2Paratek Pharmaceuticals Announces the Close of 2440 Million Private Placement to Finance Programs to Combat MRSA Infections 671 3Paratek Pharmaceuticals Announces the Close of 2440 Million Private Placement to Finance Programs to Combat MRSA Infections 671 4National Psoriasis Foundation Marks World Psoriasis Day With Call to Support Psoriasis Legislation 4669 1National Psoriasis Foundation Marks World Psoriasis Day With Call to Support Psoriasis Legislation 4669 2Lincare Holdings Inc Prices 24500 Million Convertible Senior Debentures Offering 4665 1Lincare Holdings Inc Prices 24500 Million Convertible Senior Debentures Offering 4665 2Lincare Holdings Inc Prices 24500 Million Convertible Senior Debentures Offering 4665 3
...WIRE)--Jun 12, 2007 - Inspire,Pharmaceuticals, Inc...nd collaborators related to Inspire will present,i...ademy of,Allergology and Clinical Immunology (EAAC...and at the 30th European Cystic Fibrosis,Society (...lek,Turkey., The EAACI Congress includes two pres...
...d both primary and secondary endpoints of,study; n...een,valopicitabine and ribavirin ~, CAMBRIDGE, Mas...,Pharmaceuticals, Inc. today announced results fro...bination therapy, consisting of,valopicitabine (NM...nt of hepatitis C, pegylated interferon and ribavi...
Other Medicine Technology:Inspire Announces Presentations at Two European Scientific,Conferences 2Inspire Announces Presentations at Two European Scientific,Conferences 3Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 2Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 3Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 4Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 5Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 6
...te is a synonym for pipetting accuracy, a smooth s...perating comfort. Its single, multifunctional butt...w-out as well as eject the tip. Product features:...curacy and precision. Ejection sleeve can be remo...
Since 1991 Intersurgical Incorporated manufactures high efficiency breathing filters, heat and moisture exchangers, ventilator circuits, oxygen therapy products, hand-held nebulizers and an extensive
... the right product for any patient ranging from pe...patients with tracheotomies. These products offer ...itical care applications., ,The Unti-Mist HME and...ts and staff members. This entire product line of ...
Passive heat and moisture exchangers for respiratory applications.
Medicine Products: